The global pharmaceutical asset performance management (APM) market is expected to grow at a CAGR of 7.2% during the forecast period, from 2021 to 2030. The APM market is segmented on the basis of type, application, and region. The asset integrity management segment accounted for the largest share in the APM market in 2018 and is expected to continue its dominance throughout the forecast period. Asset reliability management accounted for a significant share in 2018 and is expected to grow at a CAGR of 8% during the forecast period. Large enterprises are projected to account for more than 50% of total revenue generated by APM solutions providers by 2030 end. North America was estimated as leading region with respect to revenue generation in 2018 and it will continue its dominance throughout the forecast period with an estimated CAGR of 8%.
Some Of The Growth Factors Of This Market:
- The pharmaceutical industry is one of the most profitable industries in the world, with a global market size of $1 trillion.
- Pharmaceutical companies are increasingly investing in R&D to develop new drugs and treatments for diseases such as cancer, diabetes, Alzheimer's disease, and Parkinson's disease.
- The aging population will also drive growth in the pharmaceutical industry as more people live longer due to improved healthcare standards.
- Increasing demand for generic drugs will also drive growth in the pharmaceutical industry.
Industry Growth Insights published a new data on “Pharmaceutical Asset Performance Management (APM) Market”. The research report is titled “Pharmaceutical Asset Performance Management (APM) Market research by Types (Asset Integrity Management, Asset Reliability Management, Other), By Applications (Large Enterprises, SMEs, ), By Players/Companies GE (US), Rockwell Software (US), AVEVA Group plc (UK), Bentley Systems (US), AspenTech (US), Nexus Global (US), SAP (Germany), ”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Pharmaceutical Asset Performance Management (APM) Market Research Report
By Type
Asset Integrity Management, Asset Reliability Management, Other
By Application
Large Enterprises, SMEs,
By Companies
GE (US), Rockwell Software (US), AVEVA Group plc (UK), Bentley Systems (US), AspenTech (US), Nexus Global (US), SAP (Germany),
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
237
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global Pharmaceutical Asset Performance Management (APM) Market Report Segments:
The global Pharmaceutical Asset Performance Management (APM) market is segmented on the basis of:
Types
Asset Integrity Management, Asset Reliability Management, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Large Enterprises, SMEs,
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GE (US)
- Rockwell Software (US)
- AVEVA Group plc (UK)
- Bentley Systems (US)
- AspenTech (US)
- Nexus Global (US)
- SAP (Germany)
Highlights of The Pharmaceutical Asset Performance Management (APM) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Asset Integrity Management
- Asset Reliability Management
- Other
- By Application:
- Large Enterprises
- SMEs
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pharmaceutical Asset Performance Management (APM) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
APM is a methodology for managing pharmaceutical assets and performance. It helps identify opportunities to improve the value of a company's pharmaceutical portfolio, and makes recommendations on how best to achieve those goals. APM also provides guidance on how to measure and track progress towards asset value objectives.
Some of the major companies in the pharmaceutical asset performance management (apm) market are GE (US), Rockwell Software (US), AVEVA Group plc (UK), Bentley Systems (US), AspenTech (US), Nexus Global (US), SAP (Germany).
The pharmaceutical asset performance management (apm) market is expected to register a CAGR of 7.2%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Pharmaceutical Asset Performance Management (APM) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Pharmaceutical Asset Performance Management (APM) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Pharmaceutical Asset Performance Management (APM) Market - Supply Chain
4.5. Global Pharmaceutical Asset Performance Management (APM) Market Forecast
4.5.1. Pharmaceutical Asset Performance Management (APM) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Pharmaceutical Asset Performance Management (APM) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Pharmaceutical Asset Performance Management (APM) Market Absolute $ Opportunity
5. Global Pharmaceutical Asset Performance Management (APM) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Type
5.3.1. Asset Integrity Management
5.3.2. Asset Reliability Management
5.3.3. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Pharmaceutical Asset Performance Management (APM) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Application
6.3.1. Large Enterprises
6.3.2. SMEs
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Pharmaceutical Asset Performance Management (APM) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Pharmaceutical Asset Performance Management (APM) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Pharmaceutical Asset Performance Management (APM) Demand Share Forecast, 2019-2026
9. North America Pharmaceutical Asset Performance Management (APM) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Application
9.4.1. Large Enterprises
9.4.2. SMEs
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Type
9.7.1. Asset Integrity Management
9.7.2. Asset Reliability Management
9.7.3. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Pharmaceutical Asset Performance Management (APM) Demand Share Forecast, 2019-2026
10. Latin America Pharmaceutical Asset Performance Management (APM) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Application
10.4.1. Large Enterprises
10.4.2. SMEs
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Type
10.7.1. Asset Integrity Management
10.7.2. Asset Reliability Management
10.7.3. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Pharmaceutical Asset Performance Management (APM) Demand Share Forecast, 2019-2026
11. Europe Pharmaceutical Asset Performance Management (APM) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Application
11.4.1. Large Enterprises
11.4.2. SMEs
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Pharmaceutical Asset Performance Management (AM) Market Size and Volume Forecast by Type
11.7.1. Asset Integrity Management
11.7.2. Asset Reliability Management
11.7.3. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Pharmaceutical Asset Performance Management (APM) Demand Share, 2019-2026
12. Asia Pacific Pharmaceutical Asset Performance Management (APM) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Application
12.4.1. Large Enterprises
12.4.2. SMEs
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Type
12.7.1. Asset Integrity Management
12.7.2. Asset Reliability Management
12.7.3. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Pharmaceutical Asset Performance Management (APM) Demand Share, 2019-2026
13. Middle East & Africa Pharmaceutical Asset Performance Management (APM) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Application
13.4.1. Large Enterprises
13.4.2. SMEs
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Pharmaceutical Asset Performance Management (APM) Market Size and Volume Forecast by Type
13.7.1. Asset Integrity Management
13.7.2. Asset Reliability Management
13.7.3. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Pharmaceutical Asset Performance Management (APM) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Pharmaceutical Asset Performance Management (APM) Market: Market Share Analysis
14.2. Pharmaceutical Asset Performance Management (APM) Distributors and Customers
14.3. Pharmaceutical Asset Performance Management (APM) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. GE (US)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Rockwell Software (US)
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. AVEVA Group plc (UK)
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Bentley Systems (US)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. AspenTech (US)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Nexus Global (US)
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. SAP (Germany)
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook